Importantly, LRRC8A self- regulated its transcription via NF-κB1 and NF-κB2 pathways and the upregulation of NIK/NF-κB2/LRRC8A transcriptional axis was unfavorable for colon cancer patients [49]. The gene discussed is LRRC8A; the disease is malignant colon neoplasm.